IDEXX Laboratories Non-GAAP EPS of $2.23 beats by $0.19, revenue of $841.66M beats by $11.66M
IDEXX Laboratories press release  (NASDAQ:IDXX): Q3  Non-GAAP EPS of $2.23  beats by $0.19.
Revenue of $841.66M (+3.9% Y/Y)  beats by $11.66M.
FY2022 Outlook: Revenue of $3.325B to $3.265B vs. prior view of $3.305B to $3.385BÂ and consensus of $3.37B;Â Â operating margins of 26.3% to 26.8%; EPS outlook of $7.74 to $7.98 vs. prior outlook of $7.77 - $8.05 and consensus of $7.95.